Pathos

About Pathos

Pathos is a clinical-stage biotechnology company using AI to re-engineer drug development, focusing on Oncology and precision medicine. The company partners with biopharmaceuticals to bring patients targeted therapies by leveraging large-scale real-world data and functional genomic data to identify and validate biology that traditional methods miss. Its PathOS Platform drives biomarker development, patient selection, and trial design to accelerate clinical programs from discovery to market. Headquartered with activities in computational biology and biopharma collaborations, Pathos aims to speed the delivery of breakthrough therapies through AI-enabled drug development.